UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross‐cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3

International journal of cancer, 1999, Vol.83 (S12), p.112-118

1999

Volltextzugriff (PDF)

Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique

British journal of cancer, 1999-03, Vol.79 (7-8), p.1199

1999

Volltextzugriff (PDF)

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial

Journal of neurology, neurosurgery and psychiatry, 2011-12, Vol.82 (12), p.1344-1350

2011

Volltextzugriff (PDF)

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

The Lancet (British edition), 2015-09, Vol.386 (9997), p.974-981

2015

Volltextzugriff (PDF)

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1183-1189

2014

Volltextzugriff (PDF)

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

Journal of the neurological sciences, 2011-09, Vol.308 (1), p.98-102

2011

Volltextzugriff (PDF)

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

Multiple sclerosis, 2011-07, Vol.17 (7), p.867-875

2011

Volltextzugriff (PDF)

Idiopathic acute transverse myelitis: application of the recent diagnostic criteria

Neurology, 2005-12, Vol.65 (12), p.1950-1953

2005

Volltextzugriff (PDF)

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

Neurology, 2005-04, Vol.64 (7), p.1139-1143

2005

Volltextzugriff (PDF)

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Neurology, 2006-10, Vol.67 (7), p.1242-1249

2006

Volltextzugriff (PDF)

Survey of diagnostic and treatment practices for multiple sclerosis in Europe

European journal of neurology, 2017-03, Vol.24 (3), p.516-522

2017

Volltextzugriff (PDF)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Neurology, 2016-09, Vol.87 (10), p.978-987

2016

Volltextzugriff (PDF)

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

The New England journal of medicine, 2007-01, Vol.356 (4), p.371-378

2007

Volltextzugriff (PDF)

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.533-543

2016

Volltextzugriff (PDF)

Natural History of Multiple Sclerosis with Childhood Onset

The New England journal of medicine, 2007-06, Vol.356 (25), p.2603-2613

2007

Volltextzugriff (PDF)

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Lancet neurology, 2009-11, Vol.8 (11), p.987-997

2009

Volltextzugriff (PDF)

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Neurology, 2021-11, Vol.97 (19), p.e1870

2021

Volltextzugriff (PDF)

Neuromyelitis optica in France: a multicenter study of 125 patients

Neurology, 2010-03, Vol.74 (9), p.736-742

2010

Volltextzugriff (PDF)

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

European journal of neurology, 2018-05, Vol.25 (5), p.739-746

2018

Volltextzugriff (PDF)

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

PloS one, 2016-05, Vol.11 (5), p.e0154507-e0154507

2016

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

Neurology, 2005-04, Vol.64 (7), p.1144-1151

2005

Volltextzugriff (PDF)

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

The New England journal of medicine, 2011-10, Vol.365 (14), p.1293-1303

2011

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(79)

Sprache

Englisch
(69)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross‐cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3

Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

Idiopathic acute transverse myelitis: application of the recent diagnostic criteria

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Survey of diagnostic and treatment practices for multiple sclerosis in Europe

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis

Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Natural History of Multiple Sclerosis with Childhood Onset

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study

Neuromyelitis optica in France: a multicenter study of 125 patients

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Aktive Filter

Suchergebnisse filtern